Aimco Pesticides LtdQ2 FY23

Aimco Pesticides Ltd Q2 FY23 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹39.24Market Cap: ₹38 CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4
  • Aimco Pesticides expects business operations to pick up from FY24 onwards with additional capacity coming on stream post-expansion in Q4 FY23.
  • The company is optimistic about demand projections for FY24, supported by new product registrations in emerging markets and early customer projections.
  • Contract manufacturing revenue is anticipated to increase significantly once higher production capacity (500 tons monthly) is stabilized from January 2023.
  • Production scale-up is planned from current 100-125 tons/month to 300 tons starting January 2023, eventually reaching 500 tons.
  • Despite subdued demand in H2 FY23, strong projections and secured purchase orders support future growth.
  • New product introductions (one insecticide and one herbicide) are in the pipeline, expected to contribute to future revenue.
  • The company targets steady-state EBITDA margins between 7%-9% upon normalization of demand.

See what Aimco Pesticides Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • There is no explicit mention of any current or future fundraising plans through debt or equity in the provided transcript of Aimco Pesticides Limited's Q2 FY23 earnings conference call.
  • The discussions primarily focus on operational aspects, production capacity expansion, product registrations, demand outlook, and contract manufacturing growth.
  • No direct references were made regarding plans for raising capital via debt or equity during the call or in the related disclosures.

See what Aimco Pesticides Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes
  • Aimco Pesticides Limited has undertaken a capacity expansion project, expected to conclude by January 2023, increasing monthly production capacity to 500 metric tons.
  • There are delays in implementing the increased production capacity, now expected to start from January 2023 and stabilize over a couple of months.
  • The company is planning to initiate production at 300 tons capacity starting January 2023 and eventually ramp up to 500 tons during the year.
  • Two new products (one insecticide and one herbicide) are in the pipeline, with manufacturing decisions dependent on receiving registrations from certain markets; specific timelines are not confirmed yet.
  • The company has increased depreciation due to higher capital expenditure (CapEx) related to expansion.
  • No mention of other strategic investments beyond capacity expansion and product pipeline development during the call.

Track Aimco Pesticides Ltd — get its next earnings analysis in your feed

How does Aimco Pesticides Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature
ThisAimco Pesticides Ltd
Rev 4Mar 3

How does Aimco Pesticides Ltd rank in Fertilizers & Agrochemicals?

Compare Aimco Pesticides Ltd against every Fertilizers & Agrochemicals company (Q2 FY23) on revenue, margins and earnings-call signals.

View Fertilizers & Agrochemicals leaderboard →

Others in Fertilizers & Agrochemicals this season

  • Dhanuka Agritech Ltd (Q2 FY27)

    657.51 Crores . Key investor presentation takeaways from Dhanuka Agritech Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.

  • Sharda Cropchem Ltd (Q2 FY27)

    1,051.7 Cr, up 13% YoY (Q2 FY26: Rs. Key investor presentation takeaways from Sharda Cropchem Ltd's Q2 FY27 investor presentation — and how it ranks against sec

  • Paradeep Phosphates Ltd (Q2 FY27)

    Revenue from operations for the quarter ended 30 September 2026: Rs 7,164.06 crores . Key results statement takeaways from Paradeep Phosphates Ltd's Q2 FY27 ear

  • Astec Lifescienc (Q2 FY27)

    2.3% YoY decline. Key results statement takeaways from Astec Lifescienc's Q2 FY27 results statement — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →